Protac Antibody Conjugates And Methods Of Use

Abstract

The subject matter described herein is directed to antibody-PROTAC conjugates (PACs), to pharmaceutical compositions containing them, and to their use in treating diseases and conditions where targeted protein degradation is beneficial.


Claims

Download Citation


Sign in to the Lens

Feedback